Macjerry Sunflower

Macjerry Sunflower is a prominent China-based Contract Research Organization (CRO) that offers comprehensive clinical research and regulatory services to the global pharmaceutical and biotechnology sectors. Established in 2005, the company provides end-to-end support for clinical trials, including Phase I through IV management, site monitoring, data management, and biostatistics. They are highly regarded for their deep expertise in Chinese regulatory affairs, assisting international firms in securing National Medical Products Administration (NMPA) approvals. The firm operates across diverse therapeutic fields such as oncology, cardiology, and metabolic diseases. Macjerry Sunflower's integrated service model is designed to streamline the drug development process and facilitate market entry within the rapidly growing Chinese healthcare landscape.